Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
29.05
-0.15 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
28.98
-0.07 (-0.24%)
Pre-market: Apr 29, 2026, 4:59 AM EDT
RGC Market Cap
RGC has a market cap or net worth of $14.36 billion as of April 28, 2026. Its market cap has increased by 3,809.00% in one year.
Market Cap
14.36B
Enterprise Value
14.36B
1-Year Change
3,809.00%
Ranking
Category
Stock Price
$29.05
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $14.36B, an increase of 11,860.79%. That is a compound annual growth rate of 171.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 14.44B | 39.05% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 49.07B |
| Haleon | 42.16B |
| Teva Pharmaceutical Industries | 36.84B |
| United Therapeutics | 24.87B |
| Viatris | 17.26B |
| Neurocrine Biosciences | 12.87B |
| Dr. Reddy's Laboratories | 11.92B |
| Elanco Animal Health | 11.09B |